EUVIMEDEUVIMED entdecken
Crossref

Synthesis and in vitro Anti‐Inflammatory Activity of Novel Dendrobine Amide/Sulfonamide Derivatives

Zi-Wei Jiao, Han-Fei Liu, Kai-Qin Lin, Guang-Tong Xie, Hua-Yong Lou, Wei-Dong Pan, Mao-Sheng Zhang iD

Chemistry & Biodiversity · 2024-05 · 21 (5)

DOI: 10.1002/cbdv.202400030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 12.04.2024. Verfasst von Zi-Wei Jiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China. Hauptthemen laut MEDLINE: Sulfonamides, Lipopolysaccharides, Nitric Oxide Synthase Type II, Nitric Oxide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: State Key Laboratory of Functions and Applications of Medical Plants, Guizhou Medical University, Science and Technology Department of Zunyi City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A traditional Chinese medicine ingredient, dendrobine, has been demonstrated to have anti‐inflammatory properties. However, due to its poor anti‐inflammatory properties, its clinical use is limited. Consequently, we have designed and synthesized 32 new amide/sulfonamide dendrobine derivatives and screened their anti‐inflammatory activities in vitro. Experiments showed that nitric oxide (NO) generation in lipopolysaccharide (LPS)‐induced RAW264.7 cells was strongly reduced by derivative 14 , with an IC 50 of 2.96 μM. Western blot research revealed that 14 decreased the concentration‐dependent expression of cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (INOS). Molecular docking was used to predict the binding of the inflammation‐associated proteins COX‐2 and INOS to compound 14 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesLipopolysaccharidesNitric Oxide Synthase Type IINitric OxideCyclooxygenase 2Molecular Docking SimulationAmidesAnimalsMiceRAW 264.7 CellsStructure-Activity RelationshipAnti-Inflammatory AgentsMolecular StructureDose-Response Relationship, DrugAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

Amide/sulfonamideAnti-inflammatoryDendrobineNatural productsStructural modification

Substanzen

SulfonamidesLipopolysaccharidesNitric Oxide Synthase Type IINitric OxideCyclooxygenase 2AmidesAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China.
  • State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, PR China.
  • Natural Products Research Center of Guizhou Province, Guiyang, 550014, PR China.
  • School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, PR China.

ORCID-Profile: Mao-Sheng Zhang

Förderung

  • State Key Laboratory of Functions and Applications of Medical Plants, Guizhou Medical University
  • Science and Technology Department of Zunyi City

Zitieren

APA

Jiao, Z. W., Liu, H. F., Lin, K. Q., Xie, G. T., Lou, H. Y., Pan, W. D., & Zhang, M. S. (2024). Synthesis and in vitro Anti‐Inflammatory Activity of Novel Dendrobine Amide/Sulfonamide Derivatives. Chemistry & Biodiversity, 21(5). https://doi.org/10.1002/cbdv.202400030

Vancouver

Jiao ZW, Liu HF, Lin KQ, Xie GT, Lou HY, Pan WD, et al. Synthesis and in vitro Anti‐Inflammatory Activity of Novel Dendrobine Amide/Sulfonamide Derivatives. Chemistry & Biodiversity. 2024;21(5). doi:10.1002/cbdv.202400030

BibTeX
@article{Jiao2024,
  author = {Jiao, Zi-Wei and Liu, Han-Fei and Lin, Kai-Qin and Xie, Guang-Tong and Lou, Hua-Yong and Pan, Wei-Dong and Zhang, Mao-Sheng},
  title = {Synthesis and in vitro Anti‐Inflammatory Activity of Novel Dendrobine Amide/Sulfonamide Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  volume = {21},
  number = {5},
  doi = {10.1002/cbdv.202400030}
}
Kostenlos starten →